Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy

被引：0
|
作者：
Yu-Te Huang
Peng-Tai Tien
Po-Yu Chen
Chi-Lan Yang
San-Ni Chen
机构：
[1] China Medical University Hospital,Department of Ophthalmology, Eye Center
[2] China Medical University,School of Medicine, College of Medicine
来源：
Graefe's Archive for Clinical and Experimental Ophthalmology | 2024年 / 262卷
关键词：
Brolucizumab; Half-dose PDT; Aflibercept; Chronic central serous chorioretinopathy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1755 / 1763
页数：8
相关论文
共 50 条
  • [1] Comparative efficacy of brolucizumab, half-dose photodynamic therapy, and aflibercept in managing chronic central serous chorioretinopathy
    Huang, Yu-Te
    Tien, Peng-Tai
    Chen, Po-Yu
    Yang, Chi-Lan
    Chen, San-Ni
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (06) : 1755 - 1763
  • [2] Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
    Tseng, Chien-Chi
    Chen, San-Ni
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (08) : 1070 - 1077
  • [3] Comparative efficacy of half-dose and one-third-dose photodynamic therapy in chronic central serous chorioretinopathy: a retrospective study
    Mohsen Farvardin
    Dorna Eghtedari
    Maryam Shahmohammadi
    Mohammadkarim Johari
    International Journal of Retina and Vitreous, 11 (1)
  • [4] Safety and efficacy of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, Helena Margaret Anthonia
    Diederen, Roselie M. H.
    Lamme, Martine J. C. M.
    Fauser, Sascha
    Downes, Susan M.
    Schlingemann, Reinier O.
    Hoyng, Carel C. B.
    van Dijk, Elon H. C.
    Boon, Camiel J. F.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2022, 63 (07)
  • [5] Half-dose photodynamic therapy for chronic central serous chorioretinopathy: Efficacy and safety outcomes in real world
    Neves, Filipe
    Costa, Joao
    Fonseca, Sofia
    Silva, Luis
    Agrelos, Luis
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2016, 14 : 173 - 177
  • [6] Half-Fluence Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Nicolo, Massimo
    Eandi, Chiara M.
    Alovisi, Camilla
    Grignolo, Federico M.
    Traverso, Carlo Enrico
    Musetti, Donatella
    Piccolino, Felice Cardillo
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2014, 157 (05) : 1033 - 1037
  • [7] Half-dose versus half-fluence photodynamic therapy for chronic central serous chorioretinopathy
    Matoba, Ryo
    Shiode, Yusuke
    Kawata, Tetsuhiro
    Hosokawa, Mio
    Kimura, Shuhei
    Morizane, Yuki
    Shiraga, Fumio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2014, 55 (13)
  • [8] Choroidal Structure after Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Alovisi, Camilla
    Piccolino, Felice Cardillo
    Nassisi, Marco
    Eandi, Chiara M.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
  • [9] Microperimetric evaluation of chronic central serous chorioretinopathy after half-dose photodynamic therapy
    Fujita, Kyoko
    Shinoda, Kei
    Matsumoto, Celso Soiti
    Imamura, Yutaka
    Tanaka, Etsuko
    Mizutani, Yoshihiro
    Mizota, Atsushi
    Yuzawa, Mitsuko
    CLINICAL OPHTHALMOLOGY, 2012, 6 : 1681 - 1687
  • [10] Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin
    Toeteberg-Harms, M.
    Kurz-Levin, M.
    Fleischhauer, J.
    Windisch, R.
    OPHTHALMOLOGE, 2011, 108 (10): : 947 - 951
12345